OTC · Healthcare
Curaleaf Holdings, Inc. (CURLF)
As-reported financials and recent SEC filings for Curaleaf Holdings, Inc., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$1.27B
Net income
$-231.1M
Net margin
-18.2%
Diluted EPS
$-0.35
ROE
-30.6%
P/E (TTM)
—
Market cap
—
Debt / equity
0.7×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2022 |
|---|---|---|---|---|---|
| Revenue | $1.27B | $1.33B | $1.35B | $1.28B | $1.20B |
| Gross profit | $631.0M | $640.8M | $614.4M | $626.4M | $569.8M |
| Operating income | $25.4M | $24.7M | $42.9M | $65.0M | $58.6M |
| Net income | $-231.1M | $-215.4M | $-281.2M | $-370.1M | $-205.9M |
| Diluted EPS | $-0.35 | $-0.32 | $-0.39 | $-0.52 | $-0.29 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
6-K2026-06-26
View on EDGAR →6-K2026-06-17
View on EDGAR →6-K2026-06-17
View on EDGAR →6-K2026-06-05
View on EDGAR →6-K2026-05-27
View on EDGAR →6-K2026-05-18
View on EDGAR →6-K2026-05-11
View on EDGAR →6-K2026-05-06
View on EDGAR →Go deeper on CURLF
Search Curaleaf Holdings, Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.